These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12429298)

  • 1. Evaluation of extracorporeal shock wave therapy in Peyronie's disease.
    Manikandan R; Islam W; Srinivasan V; Evans CM
    Urology; 2002 Nov; 60(5):795-9; discussion 799-800. PubMed ID: 12429298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience.
    Husain J; Lynn NN; Jones DK; Collins GN; O'Reilly PH
    BJU Int; 2000 Sep; 86(4):466-8. PubMed ID: 10971273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity.
    Strebel RT; Suter S; Sautter T; Hauri D
    Int J Impot Res; 2004 Oct; 16(5):448-51. PubMed ID: 14973523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline).
    Lebret T; Loison G; Hervé JM; Mc Eleny KR; Lugagne PM; Yonneau L; Orsoni JL; Saporta F; Butreau M; Botto H
    Urology; 2002 May; 59(5):657-61. PubMed ID: 11992835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of extracorporeal shockwave therapy for Peyronie's disease.
    Srirangam SJ; Manikandan R; Hussain J; Collins GN; O'Reilly PH
    J Endourol; 2006 Nov; 20(11):880-4. PubMed ID: 17144855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study.
    Hatzichristodoulou G; Meisner C; Gschwend JE; Stenzl A; Lahme S
    J Sex Med; 2013 Nov; 10(11):2815-21. PubMed ID: 23898925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?
    Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E
    Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracorporeal shock-wave therapy in Peyronie's disease].
    Aboian IA; Mitusov VV; Pakus OI; Grachev SV; Pavlov SV; Shestel' AN
    Urologiia; 2004; (5):39-42. PubMed ID: 15560161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative non-invasive treatment for Peyronie's disease.
    Claro JA; Passerotti CC; Figueiredo Neto AC; Nardozza A; Ortiz V; Srougi M
    Int Braz J Urol; 2004; 30(3):199-204; discussion 204. PubMed ID: 15689246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie's disease.
    Dell'Atti L; Ronchi P
    World J Urol; 2023 Sep; 41(9):2563-2568. PubMed ID: 37490060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie's disease using two different electromagnetic lithotripters.
    Rassweiler JJ; Scheitlin W; Goezen AS; Radecke F
    World J Urol; 2024 Mar; 42(1):124. PubMed ID: 38453751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peyronie's disease-the Plymouth experience of extracorporeal shockwave treatment.
    Hamm R; McLarty E; Ashdown J; Natale S; Dickinson A
    BJU Int; 2001 Jun; 87(9):849-52. PubMed ID: 11412225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
    Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
    Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
    Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
    J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease.
    Gao L; Qian S; Tang Z; Li J; Yuan J
    Int J Impot Res; 2016 Sep; 28(5):161-6. PubMed ID: 27250868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.
    Palmieri A; Imbimbo C; Longo N; Fusco F; Verze P; Mangiapia F; Creta M; Mirone V
    Eur Urol; 2009 Aug; 56(2):363-9. PubMed ID: 19473751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: long-term results.
    De Berardinis E; Busetto GM; Antonini G; Giovannone R; Gentile V
    Arch Ital Urol Androl; 2010 Jun; 82(2):128-33. PubMed ID: 20812541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial.
    Chitale S; Morsey M; Swift L; Sethia K
    BJU Int; 2010 Nov; 106(9):1352-6. PubMed ID: 20438568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current sexual functioning in 106 patients with Peyronie's disease treated with radiotherapy 9 years earlier.
    Incrocci L; Hop WC; Slob AK
    Urology; 2000 Dec; 56(6):1030-4. PubMed ID: 11113753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.
    Fojecki GL; Tiessen S; Osther PJ
    World J Urol; 2017 Jan; 35(1):1-9. PubMed ID: 27108421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.